Fresenius Medical Care Corporation (FMS) stock price

Fresenius Medical Care Corporation (FMS) is a Healthcare · Medical Care Facilities company listed on NYSE. Price $22.20 (+0.59%), Market cap $11.60B, P/E ratio 11.25, 52-week low–high $20.19 ~ $29.85.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Fresenius Medical Care Corporation are updated in real time on BlackAll Trade.

Fresenius Medical Care Corporation financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Fresenius Medical Care Corporation (FMS) stock price?

Fresenius Medical Care Corporation trades at $22.20 (+0.59%). Real-time quotes and charts are available on BlackAll Trade.

What is the Fresenius Medical Care Corporation (FMS) market cap?

Fresenius Medical Care Corporation has a market cap of about $11.60B. Its P/E ratio is 11.25.

What does Fresenius Medical Care Corporation (FMS) do?

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and relat